David Friedberg, MD
Orthopaedic Trauma · Encino, CANPI 1952629735
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,300 of the $28,241 with a category attached, or 79.0%. Stryker accounts for 89.2% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $15,432 and has fallen 97.9% since, to $318 in 2025.
Across 96 payments — averaging $294.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$25K
- Smith+Nephew$3K
- Zimmer Biomet$157
- Medartis Inc.$96
- Zimvie Inc.$86
- Globus Medical$76
- plus $141 from 4 others
Across 3 payments — averaging $9666.67 each. An ownership or investment interest held by the physician or an immediate family member.
- GLW, Inc$29K
What the payments were for
- Consulting fees$22,30079%
- Travel & lodging$1,5515%
- Food & beverage$4,39016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 67 | $25,182 |
| Smith+Nephew | 17 | $2,503 |
| Zimmer Biomet | 2 | $157 |
| Medartis Inc. | 1 | $96 |
| Zimvie Inc. | 2 | $86 |
| Globus Medical | 2 | $76 |
| Johnson & Johnson | 1 | $39 |
| Si-bone, Inc. | 2 | $38 |
| Baxter Healthcare | 1 | $37 |
| Convatec Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- T2$12,403
- VARIAX$9,209
- GAMMA$9,117
- AXSOS$6,674
- T2 ALPHA$2,000
- EVOS$1,975
- HOFFMANN$1,000
- TRIGEN InterTAN$939
- Taylor Spatial Frame$869
- TRIGEN$850
- ADAPT$800
- ASNIS$400
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$200
- OMEGA$200
- PRIME SERIES$172
- PELVIS II$136
- Connected Health Product Portfolio$114
How this compares
$28,241 in reported general payments places this provider in the 70th percentile of 106 orthopaedic trauma providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 28 | $570 |
| Naproxen | 11 | $27 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Encino
- Michael GardnerStanford$2.9M
- Aaron OsborneRedding$1.3M
- Robert Tonksla Jolla$1.3M
- John ScolaroOrange$1M
- David LowenbergSan Francisco$788K
- Eric LindvallClovis$609K
- Christopher LeeLos Angeles$475K
- Joshua GaryLos Angeles$466K
- Christopher HoshinoTorrance$356K
- Julius BishopStanford$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.